{"schema_version":"secwatch.filing_event.v1","accession":"0001520138-24-000310","form_type":"8-K","ticker":"BIVI","cik":"0001580149","company_name":"BIOVIE INC.","filed_at":"2024-09-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.623430+00:00","generated_at":"2026-05-31T02:03:45.595540+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BioVie prices $3M public offering of 1.96M units at $1.53/share with warrants","bullets":["Gross proceeds ~$3M from 1,960,800 units at $1.53 each; each unit includes share or pre-funded warrant plus 5-year warrant exercisable at $1.53.","Offering expected to close September 25, 2024; ThinkEquity acting as sole placement agent.","Net proceeds to be used for working capital and general corporate purposes.","BioVie is a clinical-stage company focused on liver disease and neurodegenerative disorders."],"urls":{"canonical":"https://secwatch.observer/filing/0001520138-24-000310","json":"https://secwatch.observer/filing/0001520138-24-000310.json","markdown":"https://secwatch.observer/filing/0001520138-24-000310.md","text":"https://secwatch.observer/filing/0001520138-24-000310.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1580149/000152013824000310/0001520138-24-000310-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1580149/000152013824000310/bivi-20240923_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T02:03:45.595540+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}